|
English
|
正體中文
|
简体中文
|
2832010
|
|
???header.visitor??? :
33591608
???header.onlineuser??? :
892
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"nardi lisa"???jsp.browse.items-by-author.description???
Showing items 1-1 of 1 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2021-03-03T10:26:43Z |
Phase ib study of ribociclib plus fulvestrant and ribociclib plus fulvestrant plus pi3k inhibitor (alpelisib or buparlisib) for HRþ advanced breast cancer
|
Tolaney, Sara M.; Im, Young Hyuck; Calvo, Emiliano; Yen-Shen Lu; Hamilton, Erika; Forero-Torres, Andres; Bachelot, Thomas; Maur, Michela; Fasolo, Angelica; Tiedt, Ralph; Nardi, Lisa; Stammberger, Uz; Abdelhady, Ahmed M.; Ruan, Shiling; Lee, Soo Chin |
Showing items 1-1 of 1 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
